Investigators will evaluate the feasibility and preliminary effectiveness of modified Cognitive Behavioral Suicide Prevention for psychosis (CBSPp) in comparison to services-as-usual (SAU) in a randomized controlled trial. Investigators will recruit adult clients receiving services at a community mental health (CMH) setting who have a schizophrenia spectrum disorder and recent suicidal thoughts or behaviors within 3 months of screening (n=60). Client participants will be screened, enrolled and randomized to the CBSPp or SAU group. A 4-wave design will include quantitative assessments at baseline (T1), 1-month after baseline (T2), 3-months after baseline (T3), and 5-months after baseline (T4) with in-depth qualitative interviews at T3 for a random sample of adults in the CBSPp group (n=10). Providers (n=12) will be trained to deliver CBSPp and be assessed from T1-T3 to evaluate the implementation process, including in-depth qualitative interviews at T3.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Calgary Depression Rating Scale (CDRS)
Timeframe: 4 time points (baseline, mid-treatment (1 month), post-treatment (3 months), and follow-up (5 months).
Positive and Negative Syndrome Scale (PANSS)
Timeframe: 4 time points (baseline, mid-treatment (1 month), post-treatment (3 months), and follow-up (5 months).
Columbia Suicide Severity Rating Scale (C-SSRS)
Timeframe: 4 time points (baseline, mid-treatment (1 month), post-treatment (3 months), and follow-up (5 months).